Genmab — Oktober 2019

[JørgenVarnæs]

vi må håbe, at der bliver samlet til bunke

[Solsen]

Nu du siger det sukkeralf. Så er det rigtigt at det er sidste melding. Tak for rettelsen.

[Sukkeralf]

Ja problemet er jo desværre at disse first in man studier tager lang tid, da opskaleringsdelen er pænt langsommelig - vil i princippet også hellere have mere fulde data, for svært at konkluderere noget på meget preliminære data alligevel.

[Sukkeralf]

Men der går jo lidt ludaman i tingene og man vil gerne have lidt kicks indimellem

[Sukkeralf]

ludoman

[peter12]

I har sikkert læst Biontechs præsentation. De kalder gen1046 deres "Lead" kandidat https://sec.report/Document/0001193125-19-264798/d635330df1a.htm

[Sukkeralf]

Står der ellers noget om Genmab samarbejdet

[E_L]

GEN1042 DuoBody-CD40x4-1BB
which was just put back on clinicaltrials in Sept https://clinicaltrials.gov/ct2/show/NCT04083599?term=NCT04083599&rank=1

[peter12]

Når de skriver "Our collaboration with Genmab potentially includes bispecific antibodies from three different classes: trans-activating, cis-activating and tumor-targeting antibodies", betyder det at de samarbejder om 3 stoffer ?

[nohope]

• potentially -

[E_L]

@Sukkeralf they do post the latest presentations used here now https://ir.genmab.com/download-library

[JørgenVarnæs]

nice. thx EL

[Sukkeralf]

I know - I was more thinking about audio from the presentation

[Sukkeralf]

Peter tror bare det er de tre områder de arbejder med, så det kan godt være flere

[E_L]

ok, but aren't recordings mostly done when a bank or something is hosting the presentation? and then they controll distribution

[E_L]

2 more videos to keep you entertained PLEIADES "the holey grail of medicine" https://www.youtube.com/watch?v=lx7x_vA7MkU

[E_L]

and GRIFFIN https://www.youtube.com/watch?v=rHx1I24cWPg

[E_L]

just in case you are not entertained enough with the price development... ;(

[peter12]

If you could find one with Rajkumar pls ?

[E_L]